Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756780 | SCV000884690 | likely benign | not provided | 2017-06-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000756780 | SCV001246042 | likely benign | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001180342 | SCV001345251 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-02-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001180342 | SCV001619151 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000756780 | SCV001823795 | likely benign | not provided | 2020-02-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001180342 | SCV002665713 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003892684 | SCV004709404 | likely benign | TGFBR2-related condition | 2021-12-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |